- Home
- GNK vs ABUS Comparison
GNK vs ABUS Comparison
Compare GNK & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNK
- ABUS
- Stock Information
- Founded
- GNK 2004
- ABUS N/A
- Country
- GNK United States
- ABUS United States
- Employees
- GNK N/A
- ABUS N/A
- Industry
- GNK Marine Transportation
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- GNK Consumer Discretionary
- ABUS Health Care
- Exchange
- GNK Nasdaq
- ABUS Nasdaq
- Market Cap
- GNK 707.2M
- ABUS 725.9M
- IPO Year
- GNK 2005
- ABUS N/A
- Fundamental
- Price
- GNK $17.67
- ABUS $3.64
- Analyst Decision
- GNK Strong Buy
- ABUS Strong Buy
- Analyst Count
- GNK 6
- ABUS 4
- Target Price
- GNK $24.20
- ABUS $5.38
- AVG Volume (30 Days)
- GNK 525.6K
- ABUS 830.2K
- Earning Date
- GNK 11-06-2024
- ABUS 11-06-2024
- Dividend Yield
- GNK 7.70%
- ABUS N/A
- EPS Growth
- GNK 527.82
- ABUS N/A
- EPS
- GNK 1.58
- ABUS N/A
- Revenue
- GNK $439,330,000.00
- ABUS $6,742,000.00
- Revenue This Year
- GNK $15.24
- ABUS N/A
- Revenue Next Year
- GNK N/A
- ABUS N/A
- P/E Ratio
- GNK $11.14
- ABUS N/A
- Revenue Growth
- GNK 11.14
- ABUS N/A
- 52 Week Low
- GNK $14.03
- ABUS $1.77
- 52 Week High
- GNK $23.43
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- GNK 59.05
- ABUS 36.59
- Support Level
- GNK $17.32
- ABUS $3.61
- Resistance Level
- GNK $17.91
- ABUS $3.81
- Average True Range (ATR)
- GNK 0.35
- ABUS 0.16
- MACD
- GNK 0.23
- ABUS -0.03
- Stochastic Oscillator
- GNK 76.08
- ABUS 34.87
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.